1/13/17: FDA Releases Discussion Paper on Oversight of LDTs. View/download pdf here .
PAMA Recommendations Delivered to Capital Hill
NILA Comments on the VALID Act of 2021 (H.R.4128/S.2209)
NILA Comments on Lab Provisions in Draft of CURES Act 2.0
Click here for up-to-date news concerning the novel Coronavirus outbreak
Click here for laboratory-related information and communications from the Centers for Disease Control and Prevention (CDC)